Literature DB >> 17699948

Bilateral Pseudomonas aeruginosa endophthalmitis following bilateral simultaneous cataract surgery.

Mohsen Bahmani Kashkouli1, Shabnam Salimi, Hossein Aghaee, Masood Naseripour.   

Abstract

A bilateral simultaneous cataract surgery (BSCS) was performed on a 67-year-old man. The surgeon had not changed the surgical settings in between the two procedures for the two eyes. The patient developed fulminant bilateral endophthalmitis a day following the BSCS. Intravitreal culture grew Pseudomonas aeruginosa . The source of infection was not found. Immediate bilateral vitrectomy and intravitreal, subconjunctival, topical and systemic antibiotic did not save the eyes. Patient ended up with bilateral visual loss.

Entities:  

Mesh:

Year:  2007        PMID: 17699948      PMCID: PMC2636017          DOI: 10.4103/0301-4738.33825

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


Bilateral simultaneous cataract surgery (BSCS) has recently gained popularity amongst ophthalmologists because of the absence of reported serious postoperative complications.1,2 We present an immunocompetent case of bilateral Pseudomonas aeruginosa endophthalmitis (PE) following an uneventful BSCS. To the best of our knowledge, this is the second case of bilateral endophthalmitis following a BSCS in an immunocompetent patient.

Case Report

Right eye phacoemulsification and intraocular lens implantation (IOL) (Acrylic foldable, AKREOSFIT, Bausch and Lomb, UK) and left eye unplanned extracapsular cataract extraction (ECCE) and IOL implantation (PMMA, Domilens, France) were performed simultaneously on a 67-year-old man. The indications for performing BSCS were bilateral significant cataract and patient′s desire to have both cataract surgeries performed at the same time. Routine operating room protocol for prevention of intraocular infection was: preoperative sterilization of surgical instruments and some of the nondisposable drapes, eyelash isolation by means of adhesive drape and povidone iodine 10% preparation of the eyelid and face just before starting the surgery; intraoperative irrigation fluid of balanced salt solution, viscoelastic injection (2% hydroxypropyl methyl cellulose, Cellugel, Alcon, Belgium) and subconjunctival injection of antibiotic (gentamicin 20 mg/0.5 ml) and steroid (dexamethasone 2 mg/0.5 ml) at the end of the operation; and postoperative patching of the eye for 24h followed by topical antibiotic drop (chloramphenicol every six hours) for three weeks and steroid (betamethasone every six hours) for four weeks. No intraoperative complications occurred in either eye. The surgeon did not change the surgical equipment in between the two eyes. The surgeon had had the same protocol of BSCS for some patients without complication. The patient developed pain and redness of both eyes associated with severe anterior chamber reaction (4 +) on the second postoperative day. Intravitreal antibiotic (vancomycin 1mg/ 0.1ml + amikacin 0.4 mg/ 0.1 ml) was administered and antibiotic eye drops (vancomycin 50 mg/ ml + amikacin 15 mg/ ml) were started. The patient did not improve and was referred to our hospital three days after the BSCS. At the time of referral, eye examination showed a visual acuity of no light perception in the right and light perception without accurate projection in the left eye, severe corneal edema and severe fibrin exudates in the anterior chamber obscuring the iris, IOL and vitreous cavity in both eyes [Fig. 1]. Immediate vitrectomy procedure, IOL removal, intravitreal (vancomycin 1 mg/ 0.1 ml + amikacin 0. mg/ 0.1 ml) and subconjunctival antibiotic injection (gentamicin 20 mg/ 0.5 ml) was performed bilaterally under general anesthesia.
Figure 1

Slit-lamp photograph of a patient with bilateral endophthalmitis following a bilateral simultaneous cataract surgery

He also received systemic (ceftazidime 1g IV q 8h) and topical antibiotics. Intravitreal culture showed Pseudomonas aeruginosa . The patient developed no light perception on both eyes a week after the operation. Cultures from different parts of the operation room, surgical equipment and irrigation fluid were negative. The surgical set culture showed negative result but it had been sterilized after the BSCS.

Discussion

Bilateral intraocular surgery causes ongoing debate and perpetual disagreement among ophthalmologists.1 Bilateral refractive error (over 2 diopters), medical, social or economic reasons and patient′s request are the main indications for a BSCS.1 It has strongly been advised to consider the BSCS as two separate surgeries.1,2 Presented case had BSCS for a social reason. The surgeon, however, had not changed the equipment in between the two eyes. Unilateral endophthalmitis after a BSCS, either ECCE or phacoemulsification, has previously been reported.2 Ozdec et al.3 recently reported a case of bilateral endophthalmitis following a BSCS that finally developed functional vision on both eyes. The present case resulted in no vision at the end. There was another BSCS performed a day before the presenting case by the same surgeon who developed unilateral Pseudomonas aeruginosa , was referred to another hospital and resulted in an evisceration. A case of unilateral uncomplicated phacoemulsification was also performed on the same day as the presenting case, but with a different surgical set, without complication. Pseudomonas endophthalmitis is associated with poor visual outcome despite prompt treatment.4 Our patient lost vision in both eyes. There are some reports of epidemic endophthalmitis after an uneventful unilateral cataract surgery.5 Such a situation after BSCS will be devastating. In conclusion, if BSCS is being performed, the surgeon needs to consider the other eye cataract surgery as a separate surgery and further needs to take care not only using separate instruments but also needs to scrub for the second time and change the cassette and phaco probe if performing phacoemulsification. The surgeon needs to consider it as another cataract surgery.
  5 in total

1.  Immediately sequential phacoemulsification performed under topical anaesthesia as day case procedures.

Authors:  M Wertheim; R Burton
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

2.  Bilateral endophthalmitis after simultaneous bilateral cataract surgery.

Authors:  Sengül C Ozdek; Zafer Onaran; Gökhan Gürelik; Onur Konuk; Abdullah Tekinşen; Berati Hasanreisoğlu
Journal:  J Cataract Refract Surg       Date:  2005-06       Impact factor: 3.351

3.  Simultaneous bilateral cataract extraction.

Authors:  A L Ramsay; C J Diaper; S N Saba; Z A Beirouty; H H Fawzi
Journal:  J Cataract Refract Surg       Date:  1999-06       Impact factor: 3.351

4.  Acute endophthalmitis outbreak after cataract surgery.

Authors:  A K Arsan; A Adişen; S Duman; B Aslan; I Koçak
Journal:  J Cataract Refract Surg       Date:  1996-10       Impact factor: 3.351

5.  Endophthalmitis caused by Pseudomonas aeruginosa.

Authors:  Charles W G Eifrig; Ingrid U Scott; Harry W Flynn; Darlene Miller
Journal:  Ophthalmology       Date:  2003-09       Impact factor: 12.079

  5 in total
  16 in total

1.  'Bilateral same-day cataract surgery should routinely be offered to patients' - no.

Authors:  A Tatham; J L Brookes
Journal:  Eye (Lond)       Date:  2012-05-25       Impact factor: 3.775

2.  'Bilateral same-day cataract surgery should routinely be offered to patients' - yes.

Authors:  F C Lam; R M H Lee; C S C Liu
Journal:  Eye (Lond)       Date:  2012-05-25       Impact factor: 3.775

3.  Simultaneous vs sequential bilateral cataract surgery for infants with congenital cataracts: Visual outcomes, adverse events, and economic costs.

Authors:  Hreem Dave; Vidya Phoenix; Edmund R Becker; Scott R Lambert
Journal:  Arch Ophthalmol       Date:  2010-08

Review 4.  Recurring themes during cataract assessment and surgery.

Authors:  Shruti Chandra; Sobha Sivaprasad; Paul G Ursell; Khayam Naderi; David O'Brart; Amar Alwitry; Mayank A Nanavaty
Journal:  Eye (Lond)       Date:  2021-04-29       Impact factor: 4.456

5.  Customized Clinical Practice Guidelines for Management of Adult Cataract in Iran.

Authors:  Zhaleh Rajavi; Mohammad Ali Javadi; Narsis Daftarian; Sare Safi; Farhad Nejat; Armin Shirvani; Hamid Ahmadieh; Saeid Shahraz; Hossein Ziaei; Hamidreza Moein; Behzad Fallahi Motlagh; Sepehr Feizi; Alireza Foroutan; Hassan Hashemi; Seyed Javad Hashemian; Mahmoud Jabbarvand; Mohammad Reza Jafarinasab; Farid Karimian; Hossein Mohammad-Rabei; Mehrdad Mohammadpour; Nader Nassiri; Mahmoodreza Panahi-Bazaz; Mohammad Reza Rohani; Mohammad Reza Sedaghat; Kourosh Sheibani
Journal:  J Ophthalmic Vis Res       Date:  2015 Oct-Dec

Review 6.  Pros and cons of immediately sequential bilateral cataract surgery (ISBCS).

Authors:  Andrzej Grzybowski; Weronika Wasinska-Borowiec; Charles Claoué
Journal:  Saudi J Ophthalmol       Date:  2016-09-28

7.  Immediate sequential bilateral cataract surgery: A 5-year retrospective analysis of 2470 eyes from a tertiary care eye center in South India.

Authors:  Sri Ganesh; Sheetal Brar; Rohit Sreenath
Journal:  Indian J Ophthalmol       Date:  2017-05       Impact factor: 1.848

8.  Economic modelling of immediately sequential bilateral cataract surgery (ISBCS) in the National Health Service based on possible improvements in surgical efficiency.

Authors:  David P O'Brart; Harry Roberts; Khayam Naderi; Jack Gormley
Journal:  BMJ Open Ophthalmol       Date:  2020-06-25

9.  Pseudomonas aeruginosa endophthalmitis following cataract surgery.

Authors:  Jason H M Lim; Tiakumzuk Sangtam; Sachin M George; Kah-Guan Au Eong
Journal:  Indian J Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 1.848

10.  Endophthalmitis Rate in Immediately Sequential versus Delayed Sequential Bilateral Cataract Surgery within the Intelligent Research in Sight (IRIS®) Registry Data.

Authors:  Megan Lacy; Timothy-Paul H Kung; Julia P Owen; Ryan T Yanagihara; Marian Blazes; Suzann Pershing; Leslie G Hyman; Russell N Van Gelder; Aaron Y Lee; Cecilia S Lee
Journal:  Ophthalmology       Date:  2021-07-13       Impact factor: 14.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.